Incidence and Predictors of Switching and Dose Change of Direct Oral Anticoagulants among Elderly Patients with Nonvalvular Atrial Fibrillation: A 5-Year Analysis of a Large Administrative Database
In the last decade, novel oral anticoagulants (NOACs) have emerged as prominent therapeutic options in non-valvular atrial fibrillation (NVAF). We analysed the clinical burden and the switching rate between all available NOACs, and their dosage change over a period of 5 years in a representative pop...
Main Authors: | Leonardo De Luca, Melania Dovizio, Diego Sangiorgi, Valentina Perrone, Luca Degli Esposti |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-03-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/12/6/2379 |
Similar Items
-
Effects of sufficient anticoagulation on ischemic stroke outcomes in patients with nonvalvular atrial fibrillation
by: Tae Jung Kim, et al.
Published: (2023-12-01) -
Prescribing Trends of Oral Anticoagulants in US Patients With Cirrhosis and Nonvalvular Atrial Fibrillation
by: Tracey G. Simon, et al.
Published: (2023-02-01) -
NOVEL ANTICOAGULANTS FOR THROMBOEMBOLIC COMPLICATIONS PREVENTION IN NONVALVULAR ATRIAL FIBRILLATION
by: D. A. Itkin, et al.
Published: (2015-02-01) -
Current Anticoagulation Statuses among Older Chinese People with Nonvalvular Atrial Fibrillation
by: Junrong Jiang, et al.
Published: (2024-02-01) -
Current guidelines and prospects for using novel oral anticoagulants for nonvalvular atrial fibrillation
by: A. V. Fonyakin
Published: (2014-12-01)